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Abstract
Background: Fundamental researches suggest that ileum presents greater adaptive potential than the jejunum.
However, few studies estimate the association between ileum and adaptive potential in human. To discover the
association, we conducted this matched case-control study.
Methods: A 1:2 pair-matched, case-control study was conducted from January 1, 2001 to January 1, 2015 in
Intestinal Rehabilition and Transplant Center. The case group was ileum predominated (IP) group and the control
group was jejunum predominated (JP) group. Demographic data, medical history and progression of each patient
were collected.
Results: There were 24 IP cases and 48 JP controls in this study. The cumulative probabilities of parenteral nutrition
(PN) weaning in IP group were higher than that in JP group. The Bristol stool scale scores of IP group were lower than
that of JP group at third month. The Cox proportional hazards regression model confirmed that IP had a higher odds
of PN weaning (OR = 2.69; 95 % CI: 1.27, 5.70, p = 0.01) as compared with JP group. The conditional logistic regression
with 1:2 matching also confirmed IP group had a higher odds (OR = 4.84; 95 % CI: 2.02, 11.56, p <0.01).
Conclusions: Our results indicated that ileum presents greater adaptive potential than the jejunum in nutrition and
fluid absorption. And a potential anatomic subtype of short bowel syndrome was proposed. Further research need to
be conducted to more fully understand the adaptive potential of ileum besides nutrition and fluid absorption.
Keywords: Short bowel syndrome, PN weaning, Ileum, Bristol stool scale, Anatomic subtype
Background
Short bowel syndrome (SBS) is a disabling malabsorptive
disease usually following massive resection of the small
intestine and characterized by the inability to maintain
their nutritional status through normal oral intake alone
[1]. For those irreversible intestinal failure patients, in-
testinal transplantation offers the potential to regain in-
testinal function and clinical nutritional autonomy.
Along with improvements in immunosuppression, op-
erative techniques and critical care, the survivals of
patient and graft have gradually increased over time [2].
Whereas, it is still low as compared with the survival of
patients who receive long-term parenteral nutrition [2, 3].
Recent years, some progress has been achieved in intes-
tinal rehabilitation therapy, especially in the pharmaco-
logic (glucagon-like peptide 2 [GLP-2] analogue and
growth hormone) treatment which may augment the
adaptive process and help patients wean off parenteral nu-
trition [4, 5]. Another important factor which effects intes-
tinal adaptation is anatomic feature, including the length,
anatomic site and function of residual intestine.
Interestingly, it seems that ileum presents greater
adaptive potential than the jejunum [2, 6]. However, as
far as we know, this conclusion is mainly concluded
from animal study [7, 8]. Therefore, our understanding
of intestinal adaptation still requires exploration in
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humans. And current study can only confirm the ileum
decrease diarrhea and steatorrhea because of its absorp-
tion of water [9]. The other benefits, such as electrolyte
balance and long transit time, are all in theory. Little
clinical evidence is found in comparing the intestinal
adaptation between ileum and jejunum.
Consequently, to further clarify the difference between
ileum and jejunum in intestinal adaptation, we con-
ducted this case-control study in our Intestinal Rehabili-
tion and Transplant Center (IRTC).
Methods
Study design
The study was performed in accordance with the Declar-
ation of Helsinki of the World Medical Association.
With the approval of Institutional Review Committee of
Jinling Hospital, we retrospectively reviewed all SBS pa-
tients between January 1, 2001 and January 1, 2013 in
IRTC, China. SBS patients were identified by searching
the diagnosis of “Short Bowel Syndrome” in the elec-
tronic medical record systems. Individual operative notes
were physician-abstracted to obtain additional patient
and operation information. A cohort of 356 SBS patients
was achieved.
We elected two groups from the cohort and defined
them as ileum predominated group (IP group, case
group) and jejunum predominated group (JP group, con-
trol group). To be eligible as a case or control, the ileo-
cecal valve and the colon were preserved in these
patients. No surgery on the stomach, duodenum, or pan-
creas. The length of the intestine was between 100 and
20 cm. All patients must have longer than 2 years of
adaptive phase and be followed. Intestine transplant-
ation, malignancy, irradiation injury and Crohn’s disease
were excluded. Benign diseases, such as mesenteric vas-
cular disease and volvulus and trauma, were included. IP
patients were defined that the ratio of residual ileum/je-
junum was larger than 4:1. Inversely, the ratio of JP pa-
tients was less than 1:4. IP cases and JP controls were
matched 1:2 randomly by sex and length of intes-
tine(±10 cm). Patients who met the inclusion criteria
were selected by two independent researchers.
Content and data collection
The primary end-point of this study was development of
intestinal adaptation, including weaning from parenteral
nutrition (PN) and tolerance of enteral nutrition (EN) or
regular diet during our study period (ending at January
1, 2015). The definition of “wean from PN” was absolute
enteral independence and intermittent PN or fluid re-
placement was not included. We used Bristol stool form
scale to score the typical stool form [10]. The secondary
end-points were the hepatobiliary complications with
PN management: steatosis, cholestasis, and gallbladder
sludge/stones. We diagnosed “Steatosis” according to
physical examination which might notice the liver was
enlarged when the abdomen was palpated, blood tests
including elevations of the serum alanine aminotransfer-
ase (ALT) and aspartate aminotransferase (AST) and
ultrasonic diagnosis. Cholestasis was defined by eleva-
tion of conjugated bilirubin >2 mg/dL. Gallbladder
sludge/stones were detected by ultrasound. Other
chronic complications, such as metabolic bone disease
and renal insufficiency, were also recorded.
Demographic, anatomic and therapeutic features of
both group patients were collected. In our center, we
had a procedure in dealing with SBS patients, which
was illustrated in Fig. 1. If SBS patients from other
medical centers were hospitalized, they would accept
bowel rest and PN therapy until nutritional status
improved and tissue edema regressed. If patients had
undergone massive enterectomy in our center, they
required PN for 7–14 days in order to maintain
hemodynamic stability and pass the crisis. All pa-
tients were provided approximately 25–30 kcal/kg/
day and 1.0–1.5 kg/day of protein. Patients would
accept EN gradually via mouth, nasogastric tube,
nasojejunal tube, percutaneous endoscopic gastrot-
omy tube or percutaneous endoscopic jejunostomy
tube. EN started with amino acid formula (Vivonex,
Nestle’, Minneapolis, USA) or peptide-based formula
(Peptisorb, Nutricia, Wuxi, China), followed by a
transition towards whole protein formula (Nutrison
or Nutrison Fiber, Nutricia, Wuxi, China). The total
calory and protein goal of EN combined PN were
consistent with those of PN. If patients developed
diarrhea, multiple antidiarrheal drugs includes anti-
motility agents, antisecretory drugs, antibiotics and
probiotics were given to effectively control fecal out-
put. Diarrhea was defined as having three or more
loose or liquid stools per day, or as having more
stools than is normal for that person. Once patients
were EN intolerance mainly including high gastric
residuals and vomiting, they would receive PN again.
If tolerated, patients would receive home parenteral
nutrition (HPN) and EN or intestinal rehabilitation
therapy (IRT) according to the intestine function and
patients’ wills. The IRT program was performed as
described by Byrne et al. in 1995 [11]. If patients
were EN tolerated but instable in body weight, they
also underwent IRT. If patients were stable in body
weight and EN tolerated, they were all encouraged
to eat small and frequent meals. Some of them re-
ceived IRT in order to wean EN and have normal
diet. We routinely followed these patients through
phone calls, and in-person visits with a well-
designed questionnaire. This questionnaire main
content included Bristol stool scale scores, starting
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and ending time of new nutrition method, BMI and
complications. Each patient was followed at least
four times at 1st, 3rd, 6th and 12th month. If patients
had not weaned off PN in first year, they would be
irregular followed-up.
Statistical analysis
Cox proportional hazards regression and conditional
logistic regression were used to estimate the odds of
PN dependence stratified by jejunoileostomy types.
Univariate analyses of demographic, anatomic and
therapeutic features were performed to describe the
study population. Missing data ranged from 0 to 5 %
for all independent variables studied. Shapiro-Wilk
W test for testing normality were conducted on all
continuous variables. Normally distributed continu-
ous variables were analyzed using Student’s t test
and paired t-test. Categorical variables were analyzed
using Chi-square test or Fisher’s exact test if ex-
pected frequency was less than five. The cumulative
percentage of patients weaned over time was plotted
using the Kaplane-Meier survivorship analysis and
log-rank test for statistical comparison. Significance
was set as p <0.05.
Results
Figure 2 illustrated the selection of patient. Eventually,
24 IP cases and 48 JP controls were selected. The demo-
graphic and clinical characteristics of both groups were
summarized in Table 1. The characteristics of JP patients
were similar to that of IP patients, but longer jejunum
(49.5 ± 26.3 cm) and shorter ileum (8.4 ± 7.1 cm).
Table 2 showed both groups had similar duration of
PN or EN support, but the duration of PN+EN was sig-
nificantly prolonged in JP group than that in IP group.
About 1/3 (33 % in IP group, 42 % in JP group) of the
patients accepted IRT. Almost all patients (88 % in IP
group, 85 % in JP group) presented diarrhea after initiat-
ing EN. Steatosis and cholestasis were the other two
main complications presented in roughly half of patients.
The incidence of gallbladder sludge/stones in IP group
was lower than that in JP group, but did not have a stat-
istical significance. The other complications were rare
during hospitalization.
The average follow-up time was 968.5 ± 252 days. The
cumulative probabilities of PN weaning were shown in
Fig. 3. The curves of two groups had statistically signifi-
cant difference (P = 0.046). The incidence of PN weaning
in IP group (83.3 %) is higher than that in JP group
(68.8 %). The changes of Bristol stool scale scores of two
groups were shown in Fig. 4. The Bristol stool scale
scores of both groups decreased to normal levels grad-
ually during 1 year follow-up. However, the score of IP
group (median, interquartile range; 4, 4–5) was signifi-
cantly lower than that of JP group (5, 5–6, p = 0.004) at
third month. The complications during follow-up were
shown in Table 2. Three patients (1 IP patient, 2 JP pa-
tients) were dead during our study period. One IP pa-
tient and one JP patient were dead caused by end-stage
liver disease and another JP patient were dead caused by
infection (suspecting catheter-related infections). There
were no statistical significances in complications during
follow-up. But the complications of nephrolithiasis, gall-
bladder sludge/stones, and metabolic bone disease may
be underestimated.
Table 3 showed adjusted odds ratio (OR) for PN weaning,
calculated by Cox proportional hazards regression. Com-
pared with JP group, IP had a significantly higher odds of
PN weaning (OR = 2.69; 95 % CI: 1.27, 5.70, p = 0.01). The
younger age (OR = 0.94; 95 % CI: 0.88, 1.00, p = 0.06) or
higher BMI (OR = 1.41; 95 % CI: 0.98, 2.03, p = 0.06) might
increase the possibility of PN weaning, but the difference
was not statistically significant. Table 3 also showed
the odds of PN weaning estimated using the 1:2 case
(IP patients) to control (JP patients) matched design.
And the IP group had a higher odds (OR = 4.84; 95 %
CI: 2.02, 11.56, p <0.01).
Discussion
As far as we know, this was the first clinical study
to address the question whether the ileum have a
better functional adaption than the jejunum. The
functional adaption included transporter/cell, crypt
cell, transit time, nutrition and fluid absorption [6].
In fact, we had more interest in nutrition and fluid
absorption. Our study suggested that the ileum pre-
dominated SBS patients were easier to wean PN than
jejunum predominated SBS patients within 1.5 years
Fig. 1 Schematic illustration of treatment procedure of short bowel syndrome and follow-up
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following resection. This result was in agreement
with previous animal study but with a shorter dur-
ation of intestinal adaptation. It was generally be-
lieved that most of intestinal adaptation in adults
occurs within 2 years following resection [12]. And
some studies suggested the adaptation can occur be-
yond 2 years especially in adults. A study which
followed 124 SBS patients who were weaned off PN
showed more than a quarter of them were weaned
off PN beyond 2 years following resection [13]. So
we inferred this type of SBS defined as type 3 anat-
omy in some studies had a faster intestinal adapta-
tion because the intact colon had a good adaptation
in nutrition and fluid absorption [14].
Diarrhea was another main difficulty affecting SBS pa-
tients’ quality of life. Massive intestinal resection, gastric
hypersecretion, intestinal bacterial overgrowth, bile acids
malabsorption and other factors contributed to diarrhea
in SBS patients [15]. In this study, the scores of Bristol
stool scale of patients were improved continuously to nor-
mal value within 1 years following resection. It seemed that
Fig. 2 Flowchart of patient inclusion and exclusion. P-J syndrome, Peutz-Jeghers syndrome







Age (years),median (range) 40(26–63) 45(30–65) 0.42
Male gender (%) 67 % 67 % 1.00
BMI, kg/m2 (Mean ± SD) 17.5 ± 2.6 18.0 ± 2.5 0.35
Transferred patients 3 5 0.29
Etiology for SBS 0.80
Mesenteric vascular disease 13 23
Small bowel volvulus 7 12





54.8 ± 28.8 57.9 ± 29.4 0.68
Jejunum, cm 7.3 ± 5.4 49.5 ± 26.3 <0.01
Ileum, cm 47.5 ± 25.0 8.4 ± 7.1 <0.01
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these patients’ diarrhea was improved more quickly as
compared to other studies [16, 17]. But as compared be-
tween groups, IP patients had better scores of Bristol stool
scale than JP patients at the third month. This result im-
plied ileum might adapt faster than jejunum in controlling
diarrhea. The ileum’s capability of bile acids absorption and
potentiality of fluid absorption might be the mechanisms.
While, the scores of Bristol stool scale had no significant
differences between the two groups after 1 year adaptation.
Besides, we found that the improvement of diarrhea always
occurs earlier than weaning PN. This was a remarkable
phenomenon which researchers should pay more attention
to when study the intestinal adaptation.
Hormone therapy became a popular method to help SBS
patients accelerate intestinal adaptation with successful ap-
plication of growth hormone and GLP-2 [18]. Some studies
showed intestinal hormones had multiple physiological ef-
fects in SBS patients because of lacking intestinal hor-
mones. For instance, secretin and cholecystokinin played
regulatory roles in hepatobiliary system which was often
disorder in SBS patients [19, 20]. Serotonin and glucose-
dependent insulinotropic peptide had a great effect on
maintaining bone mass [21, 22]. As is well known, ileum
and jejunum have different preferable hormones [18]. So
we intended to find the differences of complications be-
tween IP group and JP group in this study. But no signifi-
cant difference was found in duration of hospital stay or
follow-up.
In the regression analysis, we found IP group was associ-
ated with 2- to 5-fold greater probability of PN weaning
than JP group. Remnant intestine length was another sig-
nificantly associated factor. Besides, BMI and age were two
potential factors in borderline. These two factors were sup-
ported by previous studies among SBS patients [3, 23]. In
this study, we studied the difference between ileum and je-
junum in patients’ intestinal adaptation. The existing evi-
dence and indications suggested ileum has greater adaptive
potential than the jejunum in nutrition and fluid absorp-
tion. Whereas, it still need prospective studies to demon-
strate ileum’s adaptive potential in other aspects
Table 2 Therapic characteristics and complications of two groups
Characteristic IP group (n = 24) JP group (n = 48) p value
Time of PN (Mean ± SD, d) 10.8 ± 2.8 10.7 ± 2.4 0.87
Time of PN+EN 7.5 ± 3.1 10.3 ± 3.7 0.002
Time of EN 4.4 ± 1.7 4.8 ± 2.0 0.42
Intestinal rehabilitation therapy 8(33 %) 20(42 %) 0.49
Complications in hospital a, b
Diarrhea 21(88 %) 41(85 %) 0.71
Catheter-related infections 2(8.3 %) 3(6.3 %) 0.34
Steatosis 11(46 %) 19(40 %) 0.61
Cholestasis 5(21 %) 12(25 %) 0.22
Gallbladder sludge/stones 1(4 %) 5(10 %) 0.26
Metabolic bone disease c 2(8 %) 3(6 %) 0.34
Renal insufficiency 1(4 %) 1(2 %) 0.45
Complications during follow-up a
Death 1(4 %) 2(4 %) 0.45
Catheter-related infections 7(29 %) 16(33 %) 0.20
Steatosis 13(54 %) 23(48 %) 0.62
Cholestasis 8(33 %) 17(35 %) 0.86
Renal insufficiency 2(8 %) 5(10 %) 0.32
Nephrolithiasis d 1(4 %) 6(13 %) 0.20
Gallbladder sludge/stones d 1(4 %) 5(10 %) 0.26
Metabolic bone disease d
All cases 0(0 %) 2(4 %) 0.44
Tested cases 0/5(0 %) 2/8(25 %) 0.43
a Some are overlapping
b Occurred during hospitalization and diagnosed by the latest test results before discharge
c Diagnosed by dual-energy X-ray absorptionmetry measurements of bone mineral density in suspect patients
d Only a portion of patients were examined
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Fig. 3 Cumulative probabilities of PN weaning in IP group and JP group during follow-up
Fig. 4 Bristol stool scale scores of IP group and JP group during follow-up. * p = 0.003
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such as hormone and transit time. According to this
study, we proposed to divide type 3 anatomy SBS
into three subtypes: Type 3a, the main remnant in-
testine was jejunum; Type 3b, the main remnant in-
testine was ileum (Fig. 5); Type 3c, the mixed type.
There were several limitations of this article. This was
a retrospective cohort study with no standardization
protocol for patients to decide if and when to accept
IRT or wean PN, thus introducing potential bias from
unmeasured confounders.
Conclusions
In conclusion, we found that the length and type
(ileum or jejunum) were associated with an increased
possibility of PN weaning in SBS patients. Our re-
sults indicated that ileum presents greater adaptive
Table 3 Estimated risks of PN weaning
Unadjusted model Adjusted model
Odds ratio 95 % CI p-value Odds ratio 95 % CI p-value
a) Using Cox proportional hazards regression
IP groupa 1.74 [0.99, 3.05] 0.05 2.69 [1.27, 5.70] 0.01
Age 1.01 [0.99, 1.03] 0.59 0.94 [0.88, 1.00] 0.06
Male 0.84 [0.46, 1.54] 0.57 1.67 [0.68, 4.08] 0.26
BMI 1.06 [0.95, 1.18] 0.32 1.41 [0.98, 2.03] 0.06
Etiology for SBSb 1.14 [0.58, 2.42] 0.70 0.60 [0.28, 1.28] 0.18
Remnant intestine length 1.07 [1.05, 1.09] <0.01 1.09 [1.06, 1.12] <0.01
b) Using conditional logistic regression with 1:2 matchingc
IP group 4.84 [2.02, 11.56] <0.01
a IP group, ileum predominated group; Jejunum predominated group was reference group
b Mesenteric vascular disease was covariates; Small bowel volvulus was reference group
c IP cases and JP controls were matched by sex and length of intestine (±10 cm)
Fig. 5 Intestinal anatomic subtype of short bowel syndrome: Type 3a, the main remnant intestine is jejunum; Type 3b, the main remnant intestine
is ileum. The black line shows the anastomosis
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potential than the jejunum in nutrition and fluid ab-
sorption. Further research need to be conducted to
more fully understand the adaptive potential of
ileum besides nutrition and fluid absorption.
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